Train harder · Free ship $75+ · Gear up now
Login Register
glp 1 idiopathic intracranial hypertension

glp 1 idiopathic intracranial hypertension A retrospective cohort study assessed outcomes among patients with who received glucagon-like peptide-1 receptor agonists Efficacy and Safety of GLP‐1

SKU: 56423886717

4.7
USD28.39 USD51.39

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

doi: 10.1093/gerona/glu073 257 GuoMMiJJiangQ-MXuJ-MTangY-YTianGet al

glp 1 idiopathic intracranial hypertension A retrospective cohort study assessed outcomes among patients with who received glucagon-like peptide-1 receptor agonists Efficacy and Safety of GLP1

Software: Talha Bashir, Aisha Mohammed

glp 1 idiopathic intracranial hypertension A retrospective cohort study assessed outcomes among patients with who received glucagon-like peptide-1 receptor agonists Efficacy and Safety of GLP1

Story Source: Materials provided by The Endocrine Society

glp 1 idiopathic intracranial hypertension A retrospective cohort study assessed outcomes among patients with who received glucagon-like peptide-1 receptor agonists Efficacy and Safety of GLP1

The descriptions of potential mechanisms are based on published research and are not guarantees of individual outcomes

glp 1 idiopathic intracranial hypertension A retrospective cohort study assessed outcomes among patients with who received glucagon-like peptide-1 receptor agonists Efficacy and Safety of GLP1
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products